|
Introduction
Solvay has been prominent in the area of influenza vaccines for more than 55 years. As of January 2008 the Influenza business of Solvay Pharmaceuticals operates from a separate legal entity, Solvay Biologicals, a wholly owned subsidiary of Solvay Pharmaceuticals.
Influenza is a serious respiratory tract infection that is caused by an Influenza virus. Influenza is very
contagious. The disease usually spreads in certain periods of the year, especially winter or early spring. When healthy people catch
Influenza, it usually disappears in about one week. In contrast, influenza can cause serious complications and even death.
People at risk of these complications are people with asthma and other diseases of the respiratory tract, heart disease, diabetes and
elderly people without such underlying disease.
|
|
|
Benefits of vaccination
Influenza vaccination is the most effective measure for the prevention and control of Influenza.
Especially high-risk persons have a lot to gain from vaccination, namely a substantial reduced risk of Influenza-related pneumonia,
hospitalization or death. Vaccination also leads to considerable cost reductions, in terms of national healthcare costs but also loss
of earnings, and productivity.
|
What is influvac®?
influvac® is a sub-unit vaccine produced and marketed by Solvay Pharmaceuticals, one of the leading influenza
vaccine companies in the world. Influenza is a sub-unit vaccine, which means that it contains only those parts of the influenza virus
that are absolutely needed for effective vaccination. The sub-unit Influenza vaccine influvac® has been on the market since the early
eighties. influvac® is available in the Middle East countries and marketed by Solvay Pharmaceuticals subsidiaries. We would like to
emphasize that the information in this site is not intended to replace consultation with your physician. We strongly urge you to consult
your physician or specialist if you suspect you have Influenza, or if you wonder whether you belong to the risk groups for Influenza and
therefore should be routinely vaccinated against influenza.
|
